Monensin Improves the Effectiveness of meso-Dimercaptosuccinate when Used to Treat Lead Intoxication in Rats
2006

Monensin Enhances Lead Treatment in Rats

Sample size: 40 publication 10 minutes Evidence: moderate

Author Information

Author(s): Hamidinia Shawn A., Erdahl Warren L., Chapman Clifford J., Steinbaugh Gregory E., Taylor Richard W., Pfeiffer Douglas R.

Primary Institution: Ohio State University

Hypothesis

Can monensin improve the effectiveness of meso-dimercaptosuccinate in treating lead intoxication in rats?

Conclusion

Monensin significantly enhances the removal of lead from various tissues when used in combination with meso-dimercaptosuccinate.

Supporting Evidence

  • Monensin increased lead removal from femur, brain, and heart in rats.
  • The combination of monensin and DMSA was more effective than DMSA alone.
  • Monensin showed a tendency to enhance lead removal from liver and kidney.

Takeaway

Monensin helps get rid of lead from rats' bodies better when used with another medicine called DMSA.

Methodology

Male Sprague-Dawley rats were divided into groups and treated with lead, monensin, DMSA, or combinations of these, followed by analysis of lead levels in various tissues.

Potential Biases

Potential bias in treatment effects due to the animal model used.

Limitations

The study was conducted on rats, and results may not directly translate to humans.

Participant Demographics

Male Sprague-Dawley rats, initially weighing 245–255 g.

Statistical Information

P-Value

0.08 in kidney, 0.14 in liver

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1289/ehp.8279

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication